04/17/2017 - 5:25pm

Baxter anticipates launching seven to nine new products annually over the next few years, increasing to 10 to 15 anticipated new product launches a year beyond 2019.

04/14/2017 - 2:51pm

State senators voted 22-9 in favor of approving a measure intended to help ease the state’s growing opioid epidemic.

04/11/2017 - 11:12am

Mometasone furoate, available in 50 mcg/spray strength, is an AB-rated therapeutic equivalent to Nasonex.

04/10/2017 - 5:26pm

Alembic Pharmaceuticals’ Fluoxetine Hydrochloride tablets are used for the treatment of depression and panic disorder.

04/10/2017 - 11:45am

Multiple news outlets state company could receive $2 billion in proceeds for the company it acquired from Merck KGaA’s Merck Serono in 2010.

04/10/2017 - 11:12am

Bupropion Hydrochloride Extended-Release tablets USP (XL), 150 mg and 300 mg is indicated for the treatment of major depressive disorder and prevention of seasonal affective disorder in adults.

04/10/2017 - 10:07am

Specialty pharmaceutical company could be acquired by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA.

04/05/2017 - 2:55pm

Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, are AB-rated generic equivalents to the reference listed drug, Epzicom Tablets, 600 mg/300 mg of ViiV Healthcare.

04/04/2017 - 11:34am

Rivelsa is an estrogen/progestin COC intended for use by women to prevent pregnancy.